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A b s tra c t  Periconeoptional folate intake reduces both 
the occurrence anil recurrence risk of neural tube de­
lects. Plasm a hom ocysteine levels can be elevated in 
m others o f  a child with a neural tube defect, suggesting 
a dysfunctional folate m etabolism . Very recently we 
show ed that a com m on 677C-—>T mutation in the 5,10- 
m eihvlene tetrahydrofolate reductase sene, causing
m ocysteine and folate m etabo lism , is a genetic  risk fac 
tor for spina bifida,
Key w o rd s  H om ocysteine • Folate • Risk factor • 
5 ,10-M ethylene te trahydrofolate  reductase • Spina bifida
A b b re v ia tio n s  M TH F R  5 ,10-M ethy lene
therm olability  of the enzym e, is a risk factor for spina tetrahydrofolate reductase * N T D  Neural tube defects* 
bifida offspring. Restriction enzym e analysis of the ge- SB Spina bifida 
nomic 5 , I O-methylcne tetrahydrofolate reductase poly­
m erase chain reaction fragment revealed a significantly --------------------------------------------------------------------------------
higher prevalence o f  a +/+ genotype am ong spina bifida Introduction 
patients and their mothers. The risk for spina bifida off-
spring is the strongest if both the m other and her child 
have the m utation in the hom ozygous state. Enzymatic 
analysis showed that hom ozygosity  for the 677C —>T 
mutation causes a decreased 5> 10-methylene tetrahydro­
folate reductase activity, resulting in elevated plasma 
hom ocysteine and red blood cell folate levels and low- 
ered plasm a folate and cysteine values. This extended 
studv dem onstrates that a nucleotide substitution in the 
coding region of 5 , 10-methylene tetrahydrofolate reduc­
tase, resulting in reduced activity and an im paired ho-
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M eningo(rnyeIo)cele, encephalocele , and anencephaly 
are the most; com m on severe congenital m alform ations. 
These m alform ations arise due to failure of closure of 
the neural tube and are referred to as neural tube defects 
(NTD). Periconceptional folate adm inistration reduces 
the occurrence and recurrence risk  o f  N T D  [1, 2], Both 
genetic and environm ental factors, such as maternal nu- 
tritional status, have been p roposed  to affect the risk for 
NTD (3). The folate levels in m others o f  a child with a 
NTD are not deficient but in the low er range o f  control 
levels |4 | .  We [5] and others [6 ] have dem onstrated that 
elevated plasm a hom ocysteine levels, indicating the pres­
ence of an abnorm al folate m etabolism , are present in 
mothers o f  a child with a N TD .
Reduced activity of 5 ,10-m ethylene tetrahydrofolate 
reductase (M TH FR), a key enzym e in the folate-depen­
dent hom ocysteine m etabolism , is associated w ith elevat­
ed plasm a hom ocysteine levels [7, 8]. M T H FR  catalyzes 
the reduction of 5 , 10-m ethylene tetrahydrofolate to 5- 
m ethyltetrahydrofolate, a cosubstra te  fo r the methylation 
o f  hom ocysteine to m ethionine. T h is  report is an exten­
sion of our previous study in w hich we show ed that the 
677C —>T m utation in the M T H F R  gene is a risk factor 
for spina bifida (SB) offspring [9], w hich  has recently 
been confirm ed by others [10], T h e  6 7 7 C ^ T  mutation 
causes a redistribution o f  folates, nam ely elevated red 
cell folate and lowered p lasm a fo late  levels, and an ele­
vation o f  hom ocysteine levels in fam ily  m em bers (pa­
tients and their parents) w ith  SB offspring. T h is  mutation 
explains a substantial part o f  the observed  elevated h o ­
m ocysteine levels in m others o f  a child with SB.
In addition to the prevalence o f  the 6 7 7 C —>T muta- 
tion, vve determ ined  the activities o f  M T H FR  in isolated 
lym phocytes and exam ined  the relation o f  the G77C—»T 
m utation with tiie p lasm a hom ocyste ine , cysteine, v ita­
min B |2, red cell folate, and p lasm a folate levels in fam i­
lies with SB offspring,
6 0 2
Patients and methods
Patients with SB and their parents were recruited by BOSK, a 
Dutch society for patients with central nervous system defects and 
their parents |9], The study group consisted o f  families with sp o ­
radic SB offspring, namely 70 mothers (mean age 4 5 .7 ± l l .7  
years), 60 fathers (mean age 4 7 . f e l l . f t  years), and 55 children 
with SB {mean age 2 3 .3 + 1 1.6 years).
The control group consisted o f  volunteers recruited from a 
general practice in The Hague [11), Individuals from the practice, 
aged 2 0 -9 0  years, were invited to participate in a health survey o f  
risk factors Tor cardiovascular disease. The 207 unrelated persons 
that agreed to lake part were used as control group in the present 
study (mean age 53 .0±  12 .1 years). None o f  the controls .suffered 
from SB or had an affected child.
The investigated mutation in the MTHFR gene is a C to T su b -  
stitution at base pair ft77 altering an alanine to a valine residue. 
This mutation creates a site, designated t+), allowing restric­
tion site analysis [12). The prevalence o f  this mutation was investi­
gated by polymerase chain reaction o f  genom ic DNA and restric­
tion enzyme digestion with followed by agarose gel electro­
phoresis. The prevalence o f  the + allele in the control group was 
used to determine the expected prevalence of the genotype o f  a 
control mother and that o f  her child.
MTHFR activities were measured in lymphocytes, which were 
isolated from heparinized blood [0 |, The MTHFR* activity was d e ­
termined by a radiochemical assay in its physiological reverse d i­
rection [8 |. Activities were determined after incubation at 37 C 
and after heal inactivation for 5 min at 4ft“C. In this study
V
MTHFR activity was considered to be thermolahile when the r e ­
sidual activity after heal inactivation at 4ft'C was below 37* < o f  
the specific activity. MTHFR activities were determined in I 10 o f  
the controls.
Homocysteine and cysteine concentrations were determined in 
EDTA plasma by HPLC with fluorescence detection [13|. Folate 
and vitamin B 1: levels o f  heparinized plasma and folate levels o f  
red cells were determined by using the Dualcount Solid Phase 
Boil Radioassay (Diagnostic Products, Los Angeles. Calif, USA).
Odds ratios 1141 and 95^7 confidence intervals (05* <’ CD were 
calculated to estimate the relative risk o f  the hom ozygous muta­
tion. Results are expressed us the mean value ± standard deviation 
<SD). One-way analysis o f  variance was used to calculate the sta­
tistical significant differences between the mean values o f  the 
three di fie rent genotypes, followed by pairwise Wilcoxon rank 
sum tests. P  values were two-tailed, and P<0A)5 was considered
statistically significant. Correlation was determined In Spear 
man's correlation with a two tailed 05*, confidence interval.
iftM v*
Results
Genetic analysis revealed h o n u w u o s i tv  for the alanine 
to valine substitution (+/+) in 4.tSr r o f  the controls versus 
I5 ,7 '7  of the mothers, 10.0*7 o f the fathers, and 12.7*7 
of the affected children o f  the families with SB off­
sp r in g  as reported previously |9 |,  The determ ined odds 
ratios were 3.7 (9 5 <;i Cl: 1,5 9,1); 2.2 (95 'r  Cl:
O.K-6.3), and 2,9 (95f7  CT: 1,0 -7 .9 ) for mothers, fathers 
and children, respectively, versus controls. T he odds ra­
tio increased to 4.1 (1,5 -11.1) if the m other had a +/+ 
genotype and her child a +/•*■ genotype, and even to 6.1 
(9 5 f7  Cl: 1,0-35.5) if both the mother and her child have 
a -f/-f genotype (Table 1). Heterozygosity for the 
677C~>T mutation was observed in 4 1 ,5 ‘ r o f  the con ­
trols versus 3X.6'7  of the mothers, 41.7*7 o f the fathers 
and 47.3'.?' of the SB patients. The wild type t /  ) was 
present in 53.0/1 o f  the controls, 45.7* * of the mothers, 
4 H 3 V( o f the fathers, and 4 t).0 r< of the affected children.
'fable 2 docum ents the relationship betw een presence 
o f  the fi77C->T mutation, M TH FR activity and plasm a 
hom ocysteine levels. T he mean M THFR activities were
m
lowered in individuals with the imitation in luuno/vm nts
(+/+) and oven in hetero /vm m s (+/■■) state. In vmintllv
*
all studied subjects the +/+ genotype m atched with ther­
molahile enzym e activity |9 |,  The measured M TH FR ac­
tivities were independent of age (data not shown). H o­
mocysteine levels were elevated in controls, mothers, 
and fathers with the +/+ genotype com pared to +■/ and 
■-/■-* genotypes, but not in the children (Table 2). Since 
the plasma hom ocysteine levels are thought to increase 
with age |15  17 1, the mean hom ocysteine values o f  a f­
fected children with a 4-/+ genotype were not increased, 
probably due to their lower mean age than that of the 
children with a 4*/ or /  genotype. The mean ages 
am ong children with the different genotypes were, r e ­
spectively: +/+, 14.6 (+ 4 .h :  +/■■, 23.9 (±12,5): and /  , 
25.3 (±4 1.3) years. Since no reference data are available
m
for homoevsteine levels i*f children, we can draw no def- 
inite conclusions about the homoevsteine levels o f  the
%
children hom ozygous for the mutation.
Homozygosity for the 677C >T mutation resulted in 
significantly higher plasma hom ocysteine levels
(I7.1±ll.5 f.tmol/1) than in heterozygous individuals
Table 1 Odds ratios and 9 5 f t 
confidence intervals o f  the pos­
sible different genotype com bi­
nations of the mother and her 
child. The expected frequencies 
are determined from the allele 
frequencies observed in 207 
controls, the total expected  
number in Ihe Table is 206 due 
to rounding olT. The study 
group included 5 1 pairs of  
mothers and their child
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or - / -  (541 ±188 nmol/1) genotype. The plas- 
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mutation (9.5+3.1 nmol/1) were significantly 
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nmol/1). The plasma cysteine
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er
to methionine is regulated by S-adenosylmethiomne
. AdoMet is an al-
enzyme AdoMet donates its
UV-+
m ethyl g roup  in over a hundred  different m ethyltransfer- 
ca ta lyzed  reactions, inc lud ing  D N A -m ethylation 
. S ince reduced  M T H F R  activity  m ight cause re-
duced availability  o f  the A d o M et p recu rso r methionine, 
hypom ethy ia tion  o f  D N A  during  em bryogenesis may 
disrupt the regula tion  o f  gen es  involved in closure of the 
neural tube. T h is  could  be the underly ing  m echanism  by 
which a defic ien t M T H F R  cou ld  provoke SB or orofacial
The observed  decreased  total p lasm a cysteine levels
may also be exp la ined  by decreased  A doM et 
A doM et s tim ulates cysta th ion ine  synthase activity [.19]. 
Therefore  low A d o M et levels m ay lead to decreased con­
version o f  hom ocyste ine  via cysta th ion ine  to cysteine.
T he increased  frequency  o f  the M T H F R  677C —>T 
m utation in m others and th e ir  affected children indicates 
that this p o ly m o rp h ism  is a genetic  risk  factor for SB. In 
addition, since fo la te  adm in is tra tion  may overcom e the 
effects o f  reduced  M T H F R  activity [20], our findings 
provide an exp lana tion  for the pro tective role of folate in 
the etio logy o f  N TD .
P erieoncep tional folate adm in is tra tion  reduces the oc­
currence and  recurrence  o f  N TD  offspring  by at least 
72%  [1, 2]. H ow ever, com bina tion  o f  the frequencies of 
the m others and SB children  indicates that the 677C —»T 
m utation can  accoun t m ax im ally  fo r only 27.4%  o f the 
observed pro tective effect o f  folate (Table 1). Hence, 
there may still be o ther  defective  genes  present in the fo ­
late» vitam in B 12, and /o r hom ocyste ine  m etabolism  caus­
ing an increased  risk  o f  a SB offspring.
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